Technology Portfolio
The IDIS excelent research generates technological results capable of producing intellectual and industrial property rights, especially patents. IDIS makes these intellectual and industrial property assets available to those stakeholders in the biomedical and health sector. Our collaboration with companies interested in our technology portfolio can result in:
- Agreement for the development of technology (TRL increase) with option to a subsequent operating licence.
- An intellectual or industrial property licence agreement for its commercial use.
siRNA
Compounds and methods for cancer treatment
AF Markers
Prognosis of patients with atrial fibrillation
NTHO
Prevention or treatment of abnormal bone growth
DIGAG
Diagnosis, monitoring or prognosis of diabetes or pre-diabetes
PANCANGO
Use of obestatin as an antineoplasic agent in the treatment of pancreatic cancer
Lysoslert
Lipid nanostructure system for enzyme replacement therapy for lysosomal storage diseases
PREVINOM
Method to identify whether a subject treated with BMAs may develop osteonecrosis of the jaws
SAMBACAITÁ
Composition for the prevention and/or treatment of TLR4, COX1/2 and/or RBP4 – mediated diseases
DNTHO
Diagnosis and treatment of neurogenic heterotropic ossification
NeuProBTdCPU
Method for the treatment of neurological disorders
MIGRATX
In vitro method for the diagnosis, prognosis and response to treatment in migraine
EWP
Device for cerclage of a long bone fracture
Odontopack
Solution Package for Dentistry
- Standardising device for clinical and research photography
- Oral surgical retractor with protective accessory for particle projection techniques
- Mould for the manufacture of Patterson joint runners and Patterson tracks
- Simulator for teaching intra-oral surgical techniques
- Drill set for the treatment of peri-implant disease
Probe
Method for the diagnosis of ulcerative colitis
Glusens
Protein-based biosensor suitable for magnetic resonance imaging
COMING SOON
NANOGAS
GSDMB N-terminal domain fragments for cancer treatment
COMING SOON
PREANTIF
In vitro method for predicting the response of a patient suffering from ulcerative colitis to a treatment with anti- TNF antibodies
COMING SOON
BACMO
In vitro method for the differential diagnosis between viral and bacterial pneumonia in a patient
COMING SOON
FEN-OA
Intra-articular extended-release formulation of Fenofibrato microspheres for the treatment of osteoarthritis
COMING SOON
TAS1R3
Use of the TAS1R3 protein as a therapeutic, diagnostic and/or prognostic marker for tumors expressing this protein
COMING SOON
Nutriage
Nutritional audiovisual material based on the healthy, functional and bioactive Atlantic Diet Pyramid
COMING SOON
SINATRA
In vitro method for predicting the response of patients suffering from rheumatoid arthritis to a treatment with tumor necrosis factor (TNF)
inhibitors
COMING SOON
EpycuRT-Pro
Method for predicting, before the initiation of radiotherapy, whether a patient suffering from cancer would develop radiotherapy toxicity or radiotherapy side effects
COMING SOON
MAPRI
In vitro method to predict response in cancer patients to Pd-1 and/or Pd-I1 inhibitors
pRediCCtIO
Personalised immunotherapy in renal cancer
COMING SOON
SENCANTHER
Senolytic compounds
COMING SOON
EPIPNK
Method for monitoring or predicting whether a patient suffering from obesity is responding or will respond to a very-low-calorie ketogenic diet (VLCKD)
COMING SOON
MYcotest
Diagnosis of pneumonia caused by Mycoplasma pneumoniae
COMING SOON
OBEPyk
Method for the diagnosis and prognosis of obesity
COMING SOON
ResVIOMICS
Prognosis of infections caused by respiratory syncytial virus
COMING SOON
